Save 60% with brand name Genvoya made in Europe.
Non-english packaging - English label and English insert included. Plan in advance - allow us 7 days to ship your medicine
Manufacturer for all European Genvoya:
Gilead Sciences Ireland UC
IDA Business & Technology Park
Carrigtohill
County Cork
Ireland
Information about Genvoya (Emtricitabine/Elvitegravir/Cobicistat/Tenofovir Alafenamide)
Genvoya is a fixed-dose combination medication used for the treatment of HIV-1 infection in adults and pediatric patients. It combines four antiretroviral drugs to help control viral load and improve immune function.
Product Highlights
- FDA-approved for use in the treatment of HIV-1.
- Treatment of HIV-1 infection in adults and children weighing at least 25 kg who are either treatment-naive or have been on stable antiretroviral therapy.
Key Ingredient
- A nucleoside reverse transcriptase inhibitor (NRTI).
- An integrase strand transfer inhibitor (INSTI).
- A pharmacokinetic enhancer that boosts the effectiveness of elvitegravir.
- An NRTI with improved renal and bone safety profile compared to tenofovir disoproxil fumarate.
Key Benefits
- Simplifies treatment regimens by combining multiple active ingredients into a single daily pill.
- Effective at suppressing viral load and improving CD4 cell counts.
- Better safety profile for renal function and bone health compared to some other HIV treatments.
Direction of Use
- Take one tablet once daily with food to enhance absorption.
- Adhere to the prescribed dosage and consult a healthcare provider for any adjustments.
Safety Concerns
- Potential side effects include nausea, diarrhea, headache, and fatigue.
- Monitor for liver function abnormalities and signs of lactic acidosis, especially in patients with pre-existing liver conditions.
Avoid Genvoya (Emtricitabine/Elvitegravir/Cobicistat/Tenofovir Alafenamide) If
- You have a known hypersensitivity to any components of Genvoya.
- You have severe liver disease or are experiencing liver function impairment.
- You are taking certain medications that may interact adversely with Genvoya.
